A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of VytorinÂ® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)